drugset / Trial / NCT03830723

Personalized Insemination Treatment Study

NCT03830723

Phase 2 Completed 110 enrolled Clinique Ovo
NaSingle-groupOpen-labelTreatment

Summary

This study is intended for women undergoing their first cycle of 3 intrauterine inseminations. All 3 inseminations will be personalized by using algorithms to determine the dose of study medication.

Timeline

Start
2020-01-09
Primary completion
2021-01-20
Completion
2021-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Follitropin delta Protein / enzyme biologic

Indications